| Design and validation of a histological scoring system for nonalcoholic fatty liver disease DE Kleiner, EM Brunt, M Van Natta, C Behling, MJ Contos, OW Cummings, ... Hepatology 41 (6), 1313-1321, 2005 | 10692 | 2005 |
| The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases N Chalasani, Z Younossi, JE Lavine, M Charlton, K Cusi, M Rinella, ... Hepatology 67 (1), 328-357, 2018 | 6348 | 2018 |
| The diagnosis and management of non‐alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of … N Chalasani, Z Younossi, JE Lavine, AM Diehl, EM Brunt, K Cusi, ... Hepatology 55 (6), 2005-2023, 2012 | 4997 | 2012 |
| Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis AJ Sanyal, N Chalasani, KV Kowdley, A McCullough, AM Diehl, NM Bass, ... New England Journal of Medicine 362 (18), 1675-1685, 2010 | 3689 | 2010 |
| Mechanisms of NAFLD development and therapeutic strategies SL Friedman, BA Neuschwander-Tetri, M Rinella, AJ Sanyal Nature medicine 24 (7), 908-922, 2018 | 3053 | 2018 |
| Prevention and management of gastroesophageal varices and variceal hemorrhage in cirrhosis G Garcia‐Tsao, AJ Sanyal, ND Grace, W Carey, ... Hepatology 46 (3), 922-938, 2007 | 2991* | 2007 |
| Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities AJ Sanyal, C Campbell–Sargent, F Mirshahi, WB Rizzo, MJ Contos, ... Gastroenterology 120 (5), 1183-1192, 2001 | 2810 | 2001 |
| MAFLD: a consensus-driven proposed nomenclature for metabolic associated fatty liver disease M Eslam, AJ Sanyal, J George, A Sanyal, B Neuschwander-Tetri, ... Gastroenterology 158 (7), 1999-2014. e1, 2020 | 2467 | 2020 |
| Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial BA Neuschwander-Tetri, R Loomba, AJ Sanyal, JE Lavine, ML Van Natta, ... The Lancet 385 (9972), 956-965, 2015 | 2400 | 2015 |
| The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Gastroenterological Association, American Association for the Study of … N Chalasani, Z Younossi, JE Lavine, AM Diehl, EM Brunt, K Cusi, ... Gastroenterology 142 (7), 1592-1609, 2012 | 2092 | 2012 |
| Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease C Estes, H Razavi, R Loomba, Z Younossi, AJ Sanyal Hepatology 67 (1), 123-133, 2018 | 1996 | 2018 |
| The global NAFLD epidemic R Loomba, AJ Sanyal Nature reviews Gastroenterology & hepatology 10 (11), 686-690, 2013 | 1975 | 2013 |
| AGA technical review on nonalcoholic fatty liver disease AJ Sanyal Gastroenterology 123 (5), 1705-1725, 2002 | 1567 | 2002 |
| Modeling nafld disease burden in china, france, germany, italy, japan, spain, united kingdom, and united states for the period 2016–2030 C Estes, QM Anstee, MT Arias-Loste, H Bantel, S Bellentani, J Caballeria, ... Journal of hepatology 69 (4), 896-904, 2018 | 1527 | 2018 |
| Clinical and histologic spectrum of nonalcoholic fatty liver disease associated with normal ALT values P Mofrad, MJ Contos, M Haque, C Sargeant, RA Fisher, VA Luketic, ... Hepatology 37 (6), 1286-1292, 2003 | 1526 | 2003 |
| Rifaximin treatment in hepatic encephalopathy NM Bass, KD Mullen, A Sanyal, F Poordad, G Neff, CB Leevy, S Sigal, ... New England Journal of Medicine 362 (12), 1071-1081, 2010 | 1516 | 2010 |
| Effect of remdesivir vs standard care on clinical status at 11 days in patients with moderate COVID-19: a randomized clinical trial CD Spinner, RL Gottlieb, GJ Criner, JRA López, AM Cattelan, ... Jama 324 (11), 1048-1057, 2020 | 1460 | 2020 |
| A lipidomic analysis of nonalcoholic fatty liver disease P Puri, RA Baillie, MM Wiest, F Mirshahi, J Choudhury, O Cheung, ... Hepatology 46 (4), 1081-1090, 2007 | 1386 | 2007 |
| Comparison of noninvasive markers of fibrosis in patients with nonalcoholic fatty liver disease AG Shah, A Lydecker, K Murray, BN Tetri, MJ Contos, AJ Sanyal, ... Clinical gastroenterology and hepatology 7 (10), 1104-1112, 2009 | 1381 | 2009 |
| Effect of vitamin E or metformin for treatment of nonalcoholic fatty liver disease in children and adolescents: the TONIC randomized controlled trial JE Lavine, JB Schwimmer, ML Van Natta, JP Molleston, KF Murray, ... Jama 305 (16), 1659-1668, 2011 | 1288 | 2011 |
